Fair price for Gilead’s COVID-19 med remdesivir? $4,460, cost watchdog says

How much should Gilead Sciences charge for its now-authorized COVID-19 therapy remdesivir? Up to $4,460 per patient, an influential pricing watchdog figures.

Read full article here:

www.fiercepharma.com/marketing/gilead-s-covid-19-therapy-remdesivir-worth-4-460-per-course-says-pricing-watchdog

You might also like
Menu